Table 4.

Cell surface marker expression on GFP+ CD45+ and GFP- CD45+ human cells in the marrow or spleen of β2-microglobulin NOD/SCID mice with transplants of MIG- and Notch4-IC—transduced cord blood cells



GFP+ CD45+, %

GFP- CD45+, %

MIG
Notch4-IC
MIG
Notch4-IC
Bone marrow     
    CD34+  1.2 ± 3.4   14 ± 18*  10 ± 3.7   12 ± 4.8* 
    CD33+  44 ± 45   5 ± 18*  18 ± 7   13 ± 9  
    CD41a+  2.2 ± 3.1   7 ± 20   1.5 ± 1.6   0.5 ± 0.5  
    Glycophorin A+  6 ± 15   9 ± 23   0.1 ± 0.1   0.2 ± 0.3  
    CD11b+  37 ± 24   10 ± 9*  12 ± 5   10 ± 3.7  
    CD20+  24 ± 19   6 ± 11   28 ± 18   19 ± 3.5  
    CD3+  8 ± 21   50 ± 20*  0.4 ± 0.6   6 ± 9  
Spleen     
    CD33+  0.1 ± 0.1   0.1 ± 0.1   2.8 ± 2.3   2.8 ± 1.7  
    CD20+  63 ± 24   0.1 ± 0.1   79 ± 11   79 ± 10  
    CD3+
 
0.1 ± 0.1
 
89 ± 16
 
0.1 ± 0.1
 
0.1 ± 0.1
 


GFP+ CD45+, %

GFP- CD45+, %

MIG
Notch4-IC
MIG
Notch4-IC
Bone marrow     
    CD34+  1.2 ± 3.4   14 ± 18*  10 ± 3.7   12 ± 4.8* 
    CD33+  44 ± 45   5 ± 18*  18 ± 7   13 ± 9  
    CD41a+  2.2 ± 3.1   7 ± 20   1.5 ± 1.6   0.5 ± 0.5  
    Glycophorin A+  6 ± 15   9 ± 23   0.1 ± 0.1   0.2 ± 0.3  
    CD11b+  37 ± 24   10 ± 9*  12 ± 5   10 ± 3.7  
    CD20+  24 ± 19   6 ± 11   28 ± 18   19 ± 3.5  
    CD3+  8 ± 21   50 ± 20*  0.4 ± 0.6   6 ± 9  
Spleen     
    CD33+  0.1 ± 0.1   0.1 ± 0.1   2.8 ± 2.3   2.8 ± 1.7  
    CD20+  63 ± 24   0.1 ± 0.1   79 ± 11   79 ± 10  
    CD3+
 
0.1 ± 0.1
 
89 ± 16
 
0.1 ± 0.1
 
0.1 ± 0.1
 

Lineage-depleted cord cells were transduced with MIG or Notch4-IC (n = 4). After transduction cells were injected into the veins of sublethally irradiated β2-microglobulin NOD/SCID mice. After 9 and 12 weeks, marrow aspirations were performed and cells were stained with GFP, CD45 and CD34, glycophorin A, CD33, CD41a, CD11b, CD20, or CD3. The average percentage (± SD) of cell surface marker on CD45+ cells of the 4 experiments at week 9 and week 12 was calculated. After the animals were killed, the spleens were removed, and the spleen cells were stained with GFP, CD45 and CD33, CD20, or CD3.

*

P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal